| Metric | Q4'25 | Q1'26 | Change |
|---|---|---|---|
| Revenue | $16.2B (+6.7% YoY) | $16.9B (+4.3% YoY) | Growth decelerated 240 bps |
| Adjusted EBITDA | $3.4B (+11% YoY) | $3.45B (+1.9% YoY) | Growth collapsed 910 bps |
| Same-facility admissions | +2.4% YoY | +0.9% YoY | Volume growth weakened 150 bps |
| Same-facility equivalent admissions | +2.5% YoY | +1.3% YoY | Core volume metric decelerated 120 bps |
| ER visits | +0.5% YoY | +0.3% YoY | Emergency volumes slowed 20 bps |
| Outpatient surgery | -0.5% YoY | -1.7% YoY | Surgical volumes deteriorated 120 bps |
| Exchange equivalent admissions | +2.5% YoY in Q4 | -15% YoY | Massive swing from growth to decline |
| Uninsured equivalent admissions | Not disclosed | +16% YoY | New disclosure shows sharp increase |
| Cash flow from operations | $2.4B | $2.0B (+22% YoY) | Strong underlying improvement |
| Capital expenditures | $1.5B | $1.1B | Spending reduced $400M sequentially |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.